|
| ALOPERINE Basic information |
Product Name: | ALOPERINE | Synonyms: | (7-alpha,9-alpha)-9-de-2-piperidinyl-16,17-didehydro-ormosanine;16,17-didehydro-9-de-2-piperidinyl-,(7-alpha,9-alpha)-ormosanin;6,13-METHANO-2H-DIPYRIDO[1,2-A:3',2'-E]AZOCINE,1,3,4,6,6A,7,8,9,10,12,13,13A-DODECAHYDRO-, [6R-(6,6A,13,13A)]-;ALLOPTERIN;ALOPERIN;ALOPERINE;6,13-Methano-2H-dipyrido[1,2-a:3',2'-e]azocine, 1,3,4,6,6a,7,8,9,10,12,13,13a-dodecahydro-, (6R,6aR,13R,13aS)-;Aloperine, >=98% | CAS: | 56293-29-9 | MF: | C15H24N2 | MW: | 232.36 | EINECS: | 637-202-9 | Product Categories: | Inhibitors;Alkaloids;Herb extract | Mol File: | 56293-29-9.mol | |
| ALOPERINE Chemical Properties |
Melting point | 67-72 °C | Boiling point | 367.7±37.0 °C(Predicted) | density | 1.10±0.1 g/cm3(Predicted) | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | solubility | DMF: 0.2 mg/ml; DMSO: 0.125 mg/ml; Ethanol: 20 mg/ml; Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml | pka | 10.31±0.20(Predicted) | form | A crystalline solid | CAS DataBase Reference | 56293-29-9 |
Hazard Codes | Xn | Risk Statements | 22 | RTECS | RM2979500 |
| ALOPERINE Usage And Synthesis |
Description | The structure of this alkaloid from Sophora alopercuroides has recently been
established from NMR and mass spectrometry. | Uses | Aloperine is a quinolizidine alkaloid with potential to treat inflammatory and allergic diseases. | References | Tolkachev et al., Khim. Prir. Soedin., 11,30 (1975) |
| ALOPERINE Preparation Products And Raw materials |
|